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The concordance of autoimmune disease among identical twins is virtually always less than 50% and
often in the 25-40% range. This observation, as well as epidemic clustering of some autoimmune
diseases following xenobiotic exposure, reinforces the thesis that autoimmune disease is secondary
to both genetic and environmental factors. Because nonliving agents do not have genomes, disease
characteristics involving nonliving xenobiotics are primarily secondary to host phenotype and
function. In addition, because of individual genetic susceptibilities based not only on major
histocompatibility complex differences but also on differences in toxin metabolism, lifestyles, and
exposure rates, individuals will react differently to the same chemicals. With these comments in
mind it is important to note that there have been associations of a number of xenobiotics with
human autoimmune disease, including mercury, iodine, vinyl chloride, canavanine, organic solvents,
silica, L-tryptophan, particulates, ultraviolet radiation, and ozone. In addition, there is discussion in the
literature that raises the possibility that xenobiotics may also exacerbate an existing autoimmune
disease. In this article we discuss these issues and, in particular, the evidence for the role of
environmental agents in the initiation or progression of autoimmune conditions. With the worldwide
deterioration of the environment, this is a particularly important subject for human health. Key words:
autoimmunity, environmental agents, MHC, pollution, self-antigen, xenobiotic - Environ Health
Perspect 107(suppl 5):667-672 (1999).
http.//ehpnet1.niehs.nih.gov/docs/1999/suppl-5/667-672powell/abstract.html
Autoimmunity is an inappropriate immune
response to self-tissue antigens and, if sus-
tained, can lead to tissue damage that is
known as autoimmune disease. Individually,
with the exception ofdiabetes and thyroiditis,
autoimmune diseases are relatively uncom-
mon but collectively affect 1 in 31 Americans
(1-3). It is clear that in both humans and
animals the induction and the natural history
of autoimmune disease is multifactorial,
including both genetic and environmental
influences. In some classic autoimmune dis-
eases such as systemic lupus erythematosus
(SLE), the concordance among identical
twins is generally 25-40% (4). The younger
the patient at disease presentation, the higher
the familial risk. Experiments with different
strains of inbred mice clearly reflect the
importance ofgenetics. For example, whereas
C57 BL/6 (H-2b) mice are symptom-free fol-
lowing oral challenge with oleic acid anilide, a
severe rapid wasting disease is seen in simi-
larly challengedA/J (H-2a) mice (5). In addi-
tion, however, some data suggest that the
incidence of autoimmune disease may be
increasing and that differences in various eth-
nic and geographic populations might be
reflective, not only of genetic, but also of
environmental influences.
Autoimmune diseases occur predomi-
nantly in the Western world, yet immigrants
take on the same incidence ofdisease as the
indigenous population and in some cases
even exceed it (4). Whether the differences in
incidence between Western and Third World
nations are due to sociologic, nutritional,
parasitic, or hygienic reasons is unclear.
Although viruses and bacteria are obvious
environmental candidates and have been well
reviewed elsewhere (1), there are a number of
physical and chemical environmental factors
that clearly impact the immune system and
lead to immunopathology. These materials
include mercury (Hg), iodine (I), vinyl chlo-
ride, canavanine, ultraviolet radiation, ozone,
organic solvents, silica, ultrafine particles,
analides, and L-tryptophan. In addition, there
is the possibility that environmental chemi-
cals may influence autoimmune disease, not
only by induction, but also by exacerbation/
acceleration ofthe underlying process.
A major problem in this discussion is the
issue oflatency time. This may be a particu-
larly important problem for xenobiotics. For
example, we know that rheumatic heart dis-
ease occurs in genetically susceptible people
within a short time following exposure to a
specific serotype of 3-hemolytic streptococ-
cus. In the latter case, the association between
the infection and the clinical disease is obvi-
ous based upon this short latency interval.
On the other hand, ifthe latency time were
measured not in weeks but in many months
to years, the association would be missed and
instead ofthe disease being called rheumatic
heart disease secondary to [-hemolytic strep-
tococcus, it would be called an autoimmune
carditis with associated arthritis. It is possible
that many autoimmune diseases will have
long latency times following exposure to
xenobiotics and may, therefore, be consid-
ered hit-and-run diseases. This makes the
identification ofcausative agents very diffi-
cult to prove, particularly for diseases that
are relatively uncommon. In this article we
focus not on this concept ofhit-and-run dis-
ease or long latency time but rather on the
xenobiotics that induce autoimmunity in
humans. Following the discussion ofa num-
ber ofthese agents, we will attempt to link
them to possible pathogenic mechanisms.
Mercury
Mercury is widespread in the geosphere at low
levels but occurs in more concentrated areas as
the crude sulfide termed cinnabar. Human
intervention ofthe environment, in the form
ofmining and coalburning, has released Hg
into the biosphere and atmosphere at quanti-
tatively and qualitatively significant levels. Hg
compounds are used in fluorescent lights, bat-
teries, and electronic devices, and the metal is
still commonly used in dental amalgam for
tooth fillings. Indeed, this latter source is the
major background source ofhuman exposure
to Hgvapor (6). Disposal ofthese products is
associated with global redistribution of Hg,
chiefly through the atmosphere after incinera-
tion, although atmospheric Hg is not consid-
ered an important source in direct human
exposure (6). Awareness ofthe marked toxic-
ity ofHg compounds now prevents their use
in medications and fungicides both ofwhich
have been responsible for epidemics of Hg
toxicity. Similarly, the discharge ofHg-based
products from chemical industries into water
bodies has been associated with devastating
incidents of toxicity, most notoriously in
Minamata and then Niigata, Japan. In these
cases, methyl mercury, a particularly bioavail-
able and toxic form of Hg, was discharged
into water bodies and accumulated by fish
that were then ingested by the local popula-
tion (6). In fact, the methylation ofHg also
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occurs in the environment where aquatic
microorganisms, termed methangenic
bacteria, are able to transfer methyl groups
from methylcobalamine to Hg, forming both
monomethyl and dimethyl species of Hg.
Additional pathways have been proposed,
such as the methylation ofhomocysteine-
bound Hg by bacteria during the normal
homocysteine->methionine conversion.
Nonetheless, it is likely that man-made
changes have resulted in inorganic forms of
Hg that are more prone to environmental
methylation, compared to the naturally
occurring forms. Thus, it is the subtle expo-
sure ofHg to man (Table 1), in qualitatively
different forms, that concerns us rather than
frank toxicity, which should now be a very
rare occurrence.
It is the mercury cation (Hg2+), or
elemental Hg, following its absorption (most
often as the vapor) and intracellular oxidation
(Hg -2e- - Hg2+) that is responsible for the
toxicity ofinorganic Hg compounds (6).
Thus, mercuric chloride (HgC12) is frequently
used as a convenient source ofinorganic Hg
ions in toxicologic experiments. As a general
mechanism oftoxicity, Hg interacts rapidly
and avidly with sulfhydryl (SH) groups that
are found, for example, on thiol-containing
amino acids and proteins. The methyl mer-
cury cation (CH3Hg+) exhibits a similar high
affinity for these groups but unlike Hg2+ does
not induce metallothionein, which is protec-
tive to the host. This and its ability to easily
cross the blood-brain barrier (7) makes
CH3Hg+ particularly toxic. Methyl mercury is
dissociated over time by phagocytic cells
reforming Hg2+ ions.
Protein-Hg interactions have generated
substantial interest among immunologists,
especially in autoimmune studies, as Hg can
modify self-proteins through Hg2+-thiol
interactions. Indeed, following Hg intoxica-
tion, a membranous nephropathy that may
be autoimmune in nature has been described
(8). In animals, a widely studied model of
Hg-induced autoimmunity is the Brown-
Norway rat, as reviewed elsewhere (8). In
these animals, subcutaneous injections of
Table 1. Mercury association with immunopathology.
In humans, Hg promotes an autoimmunelike syndrome
with immune complex deposition andglomerulonephritis.
HgCI2 inhibits the production ofIFN-'yin susceptible
Brown-Norway rats and induces the production of IL-4,
thus skewing theTh response toward Th2.
Hg2+ interacts directlywith exposed SH groups of
endogenous proteins.
Hg stimulates a T-cell-induced B-cell response against
Hg-modified proteins.
As with iodine, Hg-triggered immune responses may
then recognize native protein.
Abbreviations: Hg2+, mercury ion; Hg, mercury; HgCI2, mercuric
HgCl2 generate antibodies against the
glomerular basement membrane, leading to
immune-complex deposition in the kidney as
well as proteinuria. Autoantibodies show
specificity for extracellular matrix molecules
such as laminin, collagen, and fibronectin.
The mode ofaction is unclear, but Hg may
act initially on CD4+ T cells to stimulate B-
cell production ofantibodies. This is sug-
gested byHg's lackofB-cell antigenic activity
in vitro and characteristic IgE induction in
vivo, suggesting a T-cell-dependent isotype
switch (8). Exact mechanisms are lacking,
but recent data with isolated cells suggest
that direct interaction of Hg and self-pro-
teins may occur, leading to modification of
the molecular and antigenic properties ofthe
protein (9,10).
Using a genetically susceptible mouse
model in which injected Hg2+ interacts with
the nucleolar protein fibrillarin, Kubicka-
Muranyi et al. suggested that Hg induces
antigen presentation ofa novel Hg-fibrillarin
epitope (10). The presentation ofunaltered
fibrillarin epitopes was also upregulated and
fibrillarin-specific T-cell clones were stimu-
lated (10). Genetic control of this Hg-
induced autoimmune response has been
mapped to the H-2A region ofthe major his-
tocompatability complex (MHC) ofsuscepti-
ble mice, but the manner in which Hg targets
its protein-antigen epitope was not demon-
strated until recently (9). Pollard et al. (9)
have shown that many cysteine-rich proteins
(containing thiol groups) are not modified by
Hg. Rather, the fibrillarin molecule contains
cysteines that are not disulfide bonded, leav-
ing exposed SH groups at amino acids 105
and 274 allowing their modification by Hg.
Substitution ofonly one cysteine with the
non-thiol-containing amino acid alanine
appeared to abolish interaction with Hg,
which suggested that the overall protein
structure is also important in dictating inter-
action with Hg2+. Hg-modified fibrillarin
appears to generate T-cell responses, but
Table 2. Iodine-associated autoimmune disease.
Human studies suggest iodine involvement in the
etiology of some autoimmune thyroiditis in genetically
predisposed individuals.
1% ofthe population is affected byautoimmune thy-
roiditis, but 15% of healthy individuals have circulating
autoantibodies.
Iodine increases the incidence ofautoimmune thyroiditis
in various animal models.
Iodide is commonly ingested and oxidized to the
iodinium ion.
Iodine may increase the immunogenicity ofTg, through
conjugation ofthe iodinium ion, and immune compo-
nents maythen recognize noniodinated Tg.
The oxidizing and halogenating potential of iodine
should also be considered intissue damage.
Tg, thyroglobulin.
subsequent antibodies from T-cell-primed
B cells recognize unmodified fibrillarin, lead-
ing to potentiation of an immune response.
Many patients with scleroderma possess anti-
nudeolar autoantibodies, some ofwhich react
with fibrillarin. Although there is little evi-
dence ofHg loading in these patients, similar
chemical modification at the exposed cys-
teines of fibrillarin has been proposed and
maylead to reactive antibodies (9).
Iodine
Thyroglobulin is a 660-kDa glycoprotein
iodinated at certain tyrosine residues andthen
cleaved to produce the two major thyroid
hormones triiodothyronine (T3) and
tetraiodothyronine, which is also termed thy-
roxine (T4). T3 and T4, which differ by their
degree ofiodination, are carried in plasma
primarily by thyroxine-binding globulin.
Their production and secretion is regulated
by the pituitary-derived thyroid-stimulating
hormone termed thyrotropin, which in turn
is regulated by feedback inhibition as well as
by the hypothalamus.
Autoimmune thyroiditis is characterized
by lymphocytic infiltration and generation
of autoantibodies that recognize thyroid-
related molecules including thyrotropin and
its receptors, the Na-I symporter (rNIS),
thyroglobulin, T3, and T4 (8,11,12).
Alterations in frequency of CD5+ B cells,
CD8+ T cells and y6 T cells have been associ-
ated with disease, as have the cytokines tumor
necrosis factor-a, interleukin (IL)-2, IL-6, IL-
12, and interferon (IFN)-y. Again, genetic
susceptibility is clearly important in the initia-
tion ofdisease although the determining sus-
ceptibility loci have not been identified. In
addition, however, there is dearevidence from
studies both in man and animals that dietary
iodide enhances susceptibility to autoimmune
thyroiditis (Table 2).
Iodine (I) is the 64th most abundant
element in the earth's crust, existing com-
monly as iodates and iodides in seawater and
marine organisms. As discussed above, iodine
has high affinity for thyroid hormones, so
80% of total body iodine is maintained in
the thyroid by a specific iodide pump. The
element is essential for normal thyroid func-
tion and although most individuals tolerate a
wide range ofdietary levels, some are dearly
prone to the development of thyroid dys-
function (13). The toxicity of iodide has
been related to its requirement for oxidation
to the iodinum ion (21- -2e' -4 [I2] -2e -+
2I+) prior to its binding to tyrosine residues
ofthyroglobulin (8). Thus, strong interme-
diate complexes could be formed with elec-
tron donors (phospholipids) and oxidative
damage promoted (8). However, most data
point to the role ofiodine in the modifica-
tion (iodination) of thyroid glycoproteins,
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leading to direct autoimmune responses.
Abnormal processing by antigen-presenting
cells, enhancement ofMHC-peptide antigen
T-cell receptor interactions, and increasing
affinity ofantibody-antigen binding have all
been suggested as consequences ofiodination
ofthyroid glycoproteins (11).
A number of reports from several
countries have associated the prophylactic use
ofiodide supplementation with thyroid dis-
ease (8). More recently, Kahaly et al. (13)
demonstrated that iodide supplementation in
31 patients with endemic goiter induced
hypo- and hyperthyroidism in 6 of31 patients
with associated high titers ofthyroglobulin
autoantibodies. Abnormal lymphocytic infil-
trates of the thyroid gland were shown by
biopsy. Following withdrawal ofiodide sup-
plementation, thyroid function normalized,
autoantibodies fell, and lymphocytic infiltra-
tion decreased, clearly demonstrating the role
ofiodine in disease induction ofthese individ-
uals. Consistent with these results, Rose et al.
(11) have shown that peripheral blood lym-
phocytes from patients with thyroiditis prolif-
erate in response to iodinated thyroglobulin
(i.e., recognize as antigenic) but not in
response to normal (noniodinated) thyroglob-
ulin. Although animal studies in susceptible
obese-strain chickens (14) and nonobese mice
(15,16) similarly support the role ofiodine in
autoimmune thyroiditis, other data suggest
that a causal relationship must be carefully
interpreted. First, Rose et al. (11) demon-
strated equal proliferation ofperipheral blood
lymphocytes in response to iodinated thy-
roglobulin in control patients compared to
thosewith thyroiditis. Indeed, aswell as T-cell
proliferation, autoantibody responses to thy-
roid components appear frequently in the
general population butwithout associated dis-
ease. Second, autoimmune thyroid disorders
may occur even in iodine-deficient popula-
tions (17). Third, Kong et al. (18) have
shown that immunogenicity ofthyroglobulin
peptide epitopes is conventionally dependent
upon the amino acid sequence, whereas the
degree ofiodination may only enhance anti-
genicity. Together, these data suggest that
although iodide is not prerequisite for thy-
roid-related autoimmune disease, excess iodi-
nation ofthyroid glycoproteins may trigger
autoimmune responses against the iodinated
and noniodinated epitope that manifests as
diseaseonly insusceptible individuals.
Vinyl Chloride
Most reports on the synthetic resin vinyl
chloride (VC) are concerned with its muta-
genic rather than autoimmune properties
(19). However, Lernmark proposes that
although autoreactivity is important in pre-
venting tumor formation, this may be at the
cost ofdeveloping autoimmune disease (20).
Indeed, occupational exposure toVChas been
associated with mixed connective tissue dis-
ease (21) and most notably scleroderma (see
"Organic Solvents"). Individuals susceptible
to the effects ofvinyl chloride carry human
leukocyte antigen (HLA) DR5, whereas the
haplotype A1B8 DR3 defines disease severity
(8). Markers ofdisease indude autoantibodies
to ribonuclear proteins, Raynaud syndrome,
and arthritis (8). Although VC may bind to
nucleotides, its oxidized metabolites, chloro-
ethylene oxide and chloroacetaldehyde, are
also highly reactive and bind to SH groups
(19). As with Hg, binding to SH groups of
protein-thiols may significantly modify the
protein, thus altering its antigenicity. In addi-
tion, preferential inactivation ofcytotoxic
(CD8+) T cells has been proposed following
oxidation ofcellular thiols (8). The inactiva-
tion ofCD8+ cells and loss therefore ofsup-
pressor activity, might be acontributing factor
to the autoimmune response.
Canavanine
Canavanine is an analogue of L-arginine
produced by plants to reduce their palatibility.
Dietary canavanine, obtained through alfalfa,
has been implicated in SLE-like syndromes
(22) and SLE has even been induced experi-
mentally in macaques by feeding them alfalfa
seeds (8). The monkeys developed autoim-
mune hemolytic anemia, antibodies to double-
stranded DNA, immune complex-mediated
glomerulonephritis, and arteritis. Autoanti-
bodiescontinued forup to 2yearsafterdiscon-
tinuation ofalfalfa from the diet. In vitro, high
doses ofcanavanine inhibit DNA synthesis in
murine leukocytes; lower doses selectively
inhibit B-cell function (22). In contrast to
L-arginine, which has a pI of 10.8, the pl for
canavanine is 8.2. Following its ingestion and
uptake, it may substitute for arginine in
endogenous proteins, modifyingtheirstructure
and function. Surface changes in the B cells of
autoimmune mice were altered by dietary
canavanine (23) and other studies have shown
that proliferative responses ofhuman periph-
eral T cells, notably cytotoxic (CD8+) T cells,
are inhibited by this nonessential amino acid
(24). The combination ofsurface modifica-
tion of B cells and inhibition ofCD8+ cells
could potentially lead to loss oftolerance.
More directly, however, the substitution of
arginine by canavanine, perhaps at the level of
transfer RNAarg in mammals, would render
self-moleculesimmunogenic.
Ultraviolet Radiation
and Ozone
Ozone is one ofthe most powerful oxidizing
agents known and one ofthe most difficult
air pollutants to control (25). The major
source ofozone in the atmosphere is from the
use ofpetroleum products, although it occurs
naturally in the stratosphere and, ironically,
forms a protective layer to our exposure to
UV radiation (26). Both ozone and UV radi-
ation have significant immunosuppressive
activity. Exposure ofexperimental animals to
ozone leads to decreased numbers ofresident
alveolar macrophages, probably through
direct cell lysis (27). Their mobility and
phagocytic activity are also decreased, as are
intracellular antimicrobial enzymes such as
lysozyme and acid phosphatase (27).
Splenocytes lose responsiveness to antigens
and T-cell mitogens, and both thymic and
splenic atrophy are seen (27). In children,
ozone decreases CD4-CD8 T-cell ratios
(28). Ozone damage appears to be mediated
through reactive intermediates such as
hydroxyl radicals, singlet oxygen, and perox-
ides that may oxidize lipid membranes and
thiols and alter methylation and protein-
binding sites on DNA (25). On the basis of
these observations, it is intriguing to consider
a putative role of ozone in either the estab-
lishment or the progression of an auto-
immune disease. However, at present, there
are no substantial data that address this issue.
UV light is also associated with the induc-
tion ofsystemic immunosuppression, and
exposure ofmice to UVB radiation (280 to
320 nm) results in the development ofepider-
mal carcinoma (29). Indeed, UVB radiation is
well established as a high risk factor in skin
cancers in man. Reduction in delayed-type
hypersensitivity response and bacterial resis-
tance has also been shown for UVB exposure,
although adaptation may occur with pro-
longed exposure (30). In vitro, UVB radiation
inhibits mixed leukocyte reactions. Exposed
allogeneic stimulators display decreased MHC
class II expression and IL-2 release, whereas
UVB-irradiated responders do not proliferate
in response to allogeneic cell stimulators (29).
Hence, immunosuppression appears to be
caused by direct cellular damage and not
induction ofsuppressor mechanism. There is
no evidence as yet for the role ofozone or
UVB radiation in the induction ofautoim-
mune disease. Nonetheless, these are included
as they may have potential effects, and ozone
has alreadybeen shown to increase antigenicity
ofproteins, leading to increased IgE (31).
Further work on UV irradiation is clearly
required. At present, the association with
autoimmune disease is primarily speculative
based on in vitro data and extrapolation of
immune responses in mice.
Organic Solvents
Systemic sclerosis incorporates a broad
spectrum of immune-mediated disease. Its
major diagnostic criterion, abnormal thicken-
ing of the skin (scleroderma) proximal to
metacarpophalangeal joints, belies both its
severity and the frequent involvement of
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internal organs (32). Diffuse cutaneous and
limited cutaneous forms ofsystemic sclerosis
are widely accepted subdivisions ofdisease,
and in both, antinuclear autoantibodies are
common (- 90%) (32).
An increased risk of systemic sclerosis
appears to be associated with occupational
exposure to organic solvents. A recent epi-
demiologic study confirmed solvent-disease
associations with systemic sclerosis, particu-
larly among patients positive for antibodies
against the enzyme Scl-70 (a DNA topoiso-
merase I) (33). One-quarter ofall systemic
sclerosis patients in the United States have
antibodies to Scl-70; these are marginally
more prevalent in patients with the diffuse
cutaneous form ofdisease (-35%) compared
to those with limited cutaneous disease (32).
The former showed a stronger association
with organic solvent exposure than the latter
(33). Although solvents may be categorized
into different chemical groups such as aro-
matic hydrocarbons, aliphatic hydrocarbons,
and chlorinated solvents, distinct association
between disease and asingle group is difficult.
Solvents are often mixed, and their very
nature as solvents means that the role ofdis-
solved solutes cannot be excluded in disease.
The mechanisms and genetics ofsusceptibil-
ity in VC disease may provide clues to the
pathogenesis oforganic solvent disease.
Silica
The most common misconceptions that have
confused biologic data on silicon-containing
molecules are either that silicon, silica, sili-
cate, and silicone are roughly interchangeable
terms, or that silica, silicate, and silicone
describe single chemical entities. Through
covalent bonds with oxygen, silicon shows
extensive diversity in its degree ofpolymeriza-
tion, which is mirrored in its subsequently
varied chemistry. It is as incorrect, therefore,
to ascribe asingle biologic property to silicon-
containing molecules as it would be for
carbon-containing molecules.
Oxygen and silicon are the two most
abundant elements of the earth's crust.
Silicon rarely occurs in elemental form but
binds with oxygen to form silica ofgeneral
formula [O-Si-03]4-. In its simplest form,
silica exists as monomeric silicic acid (SiOH4)
which accounts for the vast majority (> 90%)
ofenvironmental soluble silica. However, this
occurs in equilibrium with much lower levels
of dimeric or trimeric soluble silica (34).
Silicic acid is probably the major absorbable
form ofsilica in man and has no known toxi-
city. In fact, experiments in rats and chickens
suggest that it is essential for normal growth
and development because of its interaction
with collagen (35,36).
Silicic acid is stable in solutions up to
2 mM, but it rapidly polymerizes at higher
concentrations (pH < 10) where the thermo-
dynamically stable species is insoluble (solid-
phase) silica (34). Degree ofhydration (e.g.,
glass vs sand) and age determine the crystal
structure (e.g., quartz vs amorphous silica),
surface characteristics, and pathogenicity of
particulate silica. Often cations such as
sodium, potassium, magnesium, and calcium
become incorporated within the silica matrix,
forming silicates; invariably this also involves
aluminum, which may partly substitute for
silicon, forming aluminosilicates (37).
Aluminosilicates are themselves a diverse
group ofsilicates that make up rock and soil
minerals ofthe earth, and have varying crystal
structures, elemental composition, and patho-
genicities. The weathering and cycling ofsil-
ica and silicates provide a diverse range of
silica species with physical forms and proper-
ties between soluble monomeric and solid-
phase silicas (34,38). However, pathologic
responses have only been associated with
particulate forms ofsilicaand silicates.
Silicone describes a family of man-made
polymers containing the silicon-oxygen back-
bone and organic side groups such as methyl
groups (38,39). Silicones are not ofenviron-
mental origin and will not be further dis-
cussed here. It should be mentioned,
however, that Naim et al. (40) have shown
that different formulations ofsilicone, some
ofwhich are used in breast implants, have dif-
ferent adjuvant effects in delayed-type hyper-
sensitivity reactions in rats. Clearly, as with
silica, the varying chemical makeup and phys-
ical forms ofsilicones should be considered
when assessing their toxicity.
Freshly fractured particulate silica, released
typically during mining, is recognized as a
cause oflung disease (silicosis) in certain
exposed individuals (41). Its possible role in
the induction ofautoimmune disease is less
well understood. In a survey of over 3,000
gold miners, Steenland and Brown (42)
showed that although silicosis and tuberculo-
sis were associated, as expected, with silica
exposure, risk was also increased for autoim-
mune diseases, including arthritis, SLE, and
scleroderma. In the opposite manner, Koeger
et al. (43) reviewed 764 patients with autoim-
mune connective tissue disease and showed
that in 3% ofcases (n = 24), patients were
exposed to silica chiefly through mining and
sandblasting but also through less obvious
routes such as sculpture work. Systemicsclero-
sis (see "Organic Solvents") was most preva-
lent, but rheumatoid arthritis, SLE, and
dermatomyositis also occurred. Frequency of
lung fibrosis and the crystalline silica content
of bronchoalveolar lavage specimens con-
firmed exposure to silica in these patients, and
in some, cessation ofexposure induced disease
remission, strongly suggesting a cause-and-
effect relationship (43). In a Scandinavian
study, Brown et al. (44) confirmed an
increase in autoimmune disease among
hospitalized silicotic patients, and others have
specifically implicated the development of
SLE in this patientgroup (45,46). Evidence is
dearly increasing for a role ofparticulate, crys-
talline silica in the development of auto-
immune disease in susceptible individuals.
Epidemiologic studies aimed at further inves-
tigating these links need careful planning, as
associations may previously have been missed
because ofinappropriate studydesigns (47).
Mechanisms of autoimmune induction
following exposure to particulate silica are
unclear, although an adjuvant effect is likely
(see "Particulates'). Acquired humoral immu-
nity (48), upregulation ofsoluble Fas (49),
increased macrophage sensitivity to lipopoly-
saccharides (50), and reduced antigen presen-
tation (50) have all been demonstrated.
Observations on soluble Fas are particularly
interesting given the recent findings that Fas
and Fas ligand maybe critically involved in the
pathogenesis ofHashimoto's thyroiditis (51).
Membrane Fas is expressed by many cells and
induces apoptosis in the host once bound to
the Fas ligand ofan effector cell. The Fas lig-
and is expressed not only by cytotoxic T cells
but also by cells in immunologically privileged
sites such as the eye chamber and testes. Such
cells protect themselves by inducing apoptosis
in attacking T cells that bear membrane Fas.
Indeed, the apoptotic elimination ofimmuno-
competent effector cells is considered an
important mechanism in the prevention of
autoimmunity (52). In the thyroid and under
select cytokine conditions, cells may express
both Fas ligand and membrane Fas, leading to
locally induced (fratricidal) apoptosis, so dys-
regulation ofthis mechanism would similarly
have implications in autoimmunity (51).
Soluble Fas, which is an alternatively spliced
product ofthe Fasgene, antagonizes the bind-
ingbetween membrane Fas and the Fas ligand;
elevated levels could inhibit apoptosis ofself-
recognizing clones, precipitating autoimmune
responses atalaterstage (49).
Particulates
There is increasing evidence from
epidemiologic studies that microparticles
(ultrafine or submicron particles) are associ-
ated with disease. Interest has focused on the
lung because ofthe association between air-
borne microparticles and asthma (53).
However, microparticles also make up an
increasing proportion ofthe Western diet and
have been implicated in the etiology of
Crohn's disease (54). On average, 5 mg of
titanium dioxide, for example, are now
ingested per person per day in the United
Kingdom (55), which alone makes an individ-
ual's daily intake about 1012 particles (56).
Submicron-sized particles can be surprisingly
Environmental Health Perspectives * Vol 107, Supplement 5 * October 1999 670AUTOIMMUNITYAND THE ENVIRONMENT
well absorbed in the gastrointestinal tract and
their translocation is distinct from that ofsol-
uble species (57). Three distinct partide types
have been consistently demonstrated in the
intestinal lymphoid aggregates ofman: alumi-
nosilicates, mixed silicates, and titanium diox-
ide (54). These are food additives, naturally
occurring contaminants from soil, or partides
formed de novo in the environment or intesti-
nal lumen (54). Similarly, in the atmosphere,
car exhaust fumes, industrial pollution, and
cigarette smoke have markedly increased our
exposure to neoparticulates (53). Anumber of
suggestions have been made to explain the
pathogenicity ofultrafine partides, butwepro-
pose that their relationship with morbidity is
due mainly to their influence on mucosal
antigen processing.
In contrast to soil-derived particles, those
that are newly formed in the environment or
are man-made additives have active, charged
surfaces and may adsorb luminal or environ-
mental antigens (58). The differential pro-
cessing and presentation of soluble and
particulate antigens have been well described
and may greatly affect the immune outcome.
The processing ofparticle-bound antigen is
qualitatively and quantitatively distinct to
that ofsoluble antigen (59-62). Particulate
antigen, processed and presented by macro-
phages or B cells, stimulates class II restricted
T-cell hybrids up to 105-fold more efficiently
than soluble antigen (59). Macrophages
process agreater size range ofparticulate anti-
gens compared to B cells, but both antigen-
presenting cells (APCs) generate epitopes
distinct from those from soluble antigen.
Furthermore, Sedlik et al. (60) have shown
that both T helper (Th)1 and Th2 cytokines
are produced in response to immunization
with partide-bound antigen, but in the pres-
ence ofappropriate cofactors (e.g., IL-12),
Thl cells are selectively activated. In addi-
tion, particulate antigen, unlike soluble anti-
gen, may gain entry to an alternative class I
MHCpathway, most notably in macrophages
(61). Following phagocytosis, solubilized
antigen may escape the phagosome and enter
conventional cytosolic class I processing.
Alternatively, post-Golgi combination of
phagocytosed, degraded antigen with class I
MHC may occur either intravesicularly or at
the cell surface following regurgitation.
Recent data support an intravesicular
mechanism (61). Although the trafficking of
nascent class I MHC is rare, conventionally
coupled class I MHC peptide may undergo
pH-induced decoupling during passage ofthe
acidic trans-Golgi network, allowing peptide
exchange (63). Fewer studies have specifically
investigated the processing ofparticulate anti-
gen in vivo, although Maloy et al. (64) have
shown that oral ovalbumin delivered in poly
(lactide coglycolide) microparticles results in
ovalbumin (OVA)-specific cytotoxic
lymphocyte responses and generates intestinal
IgA. Clearly, the influence ofthe physical
form ofantigen in dictating cellular uptake
and processing in the lung and gastrointestinal
tractshould becareftllyconsidered.
Anilides and L-Tryptophan
A number ofmechanisms have been proposed
by which environmental agents can modulate
immune function and induce disease. These
include oxidative damage, augmentation of
antigen-specific immune responses that may
cross react with self-tissues, and direct modu-
lation of either the afferent or efferent
immune system. It is also becoming clear that
as with most other illnesses, environmental
impacts will likely turn out to be under
genetic control. Many ofthese principles are
best illustrated by the epidemics ofeosino-
phiic myalgia with shared characteristics that
occurred nearly20 years ago (8). Forexample,
the toxic oil syndrome of Spain in 1981
involving cooking oil led to both acute and
chronic disease aswell as formation ofautoan-
tibodies to collagen, DNA, and skeletal mus-
cle. Patients who developed the disease were
exposed to adulterated rapeseed oil (8). The
primary candidate for disease induction
appeared to be fatty acid esters ofoleylanilide
and 3-(N-phenylamino)-1,2-propanediol.
Patients had high circulating levels ofIgE and
autoantibodies to collagen, DNA, and skeletal
musde. Disease association was related to the
HLA DR3 and DR4 haplotypes. The patho-
genesis oftoxic oil syndrome remains unclear.
Recent studies ofcytokine mRNA expression
in lung tissue ofaffected patients have sug-
gested that, as in animal models, both Thl
and Th2 cytokines are activated, although the
balance may be in favor ofTh2 expression
(65). Indeed, it has been hypothesized that
the associated increase in IFN-y production
mayhave activated indothiamine-2,3-dioxyge-
nase, causing abnormally rapid metabolism of
tryptophan (8). A more plausible mechanism
ofdisease was provided by a mouse model of
toxic oil syndrome (66), in which increased
levels ofmRNA for IFN-y, IL-15, and IL-6
occurred in splenocytes and circulating IgE
was induced. It was suggested that anilide
treatment led to a breakdown in tolerance,
allowingpolyclonal activation ofB cells (66).
In 1989, asecond epidemic ofeosinophiic
myalgia occurred from the intake of
L-tryptophan supplements. Eosinophilia,
myalgia, urticaria, pruritus, and fasciitis, as
well as elevated C-reactive protein and anti-
nuclear antibody were hallmarks ofdisease;
again, genetic associations were noted (8).
Supplements contaminated with 1-1'-ethyli-
denebis[tryptophan] were suspected, but
purer L-tryptophan has also induced similar
symptoms in animals andhumans, suggesting
that L-tryptophan per se contributes to
disease induction. Following L-tryptophan
administration, the Lewis rat exhibits many
symptoms ofeosinophilic myalgia, including
enhanced tryptophan metabolism and fasciitis
but not peripheral eosinophilia (8).
A number of mechanisms have been
proposed, including increased secretion of
indoleamines with decreasing IFN-ysecretion,
leading to increased collagen synthesis and
eosinophil activation. However, as above,
other reports suggest that IFN-,y is important
in the pathogenesis ofeosinophilic myalgia.
The metabolic products of L-tryptophan,
kynurenine and serotonin, are considered fib-
rinogenic agents and the latterhas been associ-
ated with scleroderma and toxic oil syndrome.
Another L-tryptophan metabolite, picolinic
acid, may activate macrophages for cytokine
production. However, mechanisms ofautoim-
mune disease caused by L-tryptophan and
contaminated oil remain unclear (8).
Conclusion
There may be multiple mechanisms
involved in the initiation and progression of
autoimmune diseases and it is therefore
unlikely that the study of autoimmune dis-
eases will consistently generate "one
inducer, one disease" etiologies (Table 3).
Because nonliving agents do not have
genomes, disease characteristics involving
nonliving xenobiotics are primarily host
functions. And because host genetic suscep-
tibilities (e.g., MHC and differences in
Table 3. Proposed mechanisms for the induction of
autoimmune disease byxenobiotics.
Alteration ofself-molecules byxenobiotics ortheir
metabolites to increase immunogenicity
Induction of immune responses thatcross-reactwith
self-molecules
Direct activation ofTh cells that lead to autoimmune
cytokine network
Oxidative cell damage
Incorporation into protein resulting in loss offunction or
increased immunogenicity
Alteration of apoptosis
Change in idiotype network
Th, Thelper.
Table 4. Variables in onset and/or exacerbation of envi-
ronmental autoimmune disease. s
Environmental agents
Chemical characteristics
Route of exposure
Dose and duration of exposure
Hostfactors
Age and sex
General immune competence
Concomitant infection/environmental exposure
Cellularcytokine environment
Genetic factors
Major histocompatibility complex
Gene polymorphisms
Level ofgene expression
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toxin metabolism), lifestyles, and exposures
to toxic agents differ, individuals may react
differently to the same toxic compounds
(Table 4). Alternatively, people may pro-
duce similar overt responses to different
inducers. This could occur if different
chemical species break tolerance mecha-
nisms and expose common or similar
autoreactive components. Such chemical
inducers may not necessarily be immuno-
genic themselves. Autoantigens tend to be
evolutionarily highly conserved and this
might partly explain the immunologic simi-
larities found among a wide array of
autoimmune diseases. One might add that
ifthe immune system evolved in response to
infectious microbes, then it was not specifi-
cally designed to cope with the physical and
chemical stresses augmented by recent
human activity. Presently, the ability to cat-
egorize unique immunologic diseases with
particular inducers may be more difficult
with toxic agents than with microbial
pathogens. However, the diagnosis and pre-
vention of these chemically induced prob-
lems should improve after sufficient
information has accumulated on the nature
and fate ofthese inducers.
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